Nyxoah Announces Commercial Launch of Genio(R) Breakthrough Therapy in the Netherlands

(Brussels:NYXH),(NasdaqGM:NYXH), Nyxoah Announces Commercial Launch of Genio(R) Breakthrough Therapy in the NetherlandsFirst Genio implants successfully performed at OLVG West and Zuyderland hospitals Mont-Saint-Guibert, Belgium – December 17, 2025, 7:05am CET / 1:05am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep […]

Nyxoah Announces Commercial Launch of Genio(R) Breakthrough Therapy in the Netherlands

Nyxoah Announces Commercial Launch of Genio(R) Breakthrough Therapy in the Netherlands GlobeNewswire December 17, 2025 Nyxoah Announces Commercial Launch of Genio(R) Breakthrough Therapy in the NetherlandsFirst Genio implants successfully performed at OLVG West and Zuyderland hospitals Mont-Saint-Guibert, Belgium – December 17, 2025, 7:05am CET / 1:05am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or

AIxC Appoints Andrew Grossman As Head of Legal Where He Will Direct the Company’s Legal, Compliance, and Governance Strategy

AIxCrypto Inc. (NASDAQ: AIXC, “AIxC” or “the Company”) today announced the appointment of Andrew Grossman as Head of Legal. In this role, Andrew will direct the Company's legal, compliance, and governance functions, managing key areas including SEC disclosures, fund and investment compliance, digital asset and Web3 protocol architecture, and major strategic and commercial agreements. https://mma.prnewswire.com/media/2847468/AIxC_Appoints_Andrew_Grossman_as_Head_of_Legal.jpg

Press Release: Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema

(Paris:SAN), Sanofi's efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema Additional orphan designation reinforces Sanofi's commitment to developing treatments for rare diseases Efdoralprin alfa, an investigational restorative recombinant therapy, recently met all primary and key secondary endpoints in phase 2 head-to-head study versus a plasma-derived standard of care Paris,

GEDU Global Education Signs Agreement with United Nations Agency UNITAR during XXII CIFAL Annual Meeting in London

UK-based education multinationalGEDU Global Education has signed an agreement with the United Nations Institute for Training and Research (UNITAR), formally committing to operate one of its 32 international training centres located around the world. The mission of the training centres is to provide capacity building programmes that support the achievement of the 17 Sustainable Development

111, Inc. Announces Third Quarter 2025 Unaudited Financial Results

— Transition from An Asset-Heavy Business Model to An Asset-Light Business Model — Achieved Quarterly Non-GAAP Net Profitability — Maintained Non-GAAP Operational Profitability for Three Consecutive Quarters — Achieved Quarterly Positive Operating Cash Flow 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of

LightingWay Counselling Offers Affordable Therapy Amid Rising Job Market Uncertainty in Singapore

Recent employment data reveals heightened job market pressures affecting mental health needs. In light of these circumstances,LightingWay Counselling & Therapy continues to provide affordable therapy services to help Singaporeans cope better with a complex, evolving job market. https://mma.prnewswire.com/media/2847404/image_5005395_10046179.jpg Singaporeans Continue to Face Job Market Challenges Going into 2026 As artificial intelligence (AI) continues to reshape

Press Release: Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema

Press Release: Sanofi's efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema GlobeNewswire December 17, 2025 Sanofi's efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema Additional orphan designation reinforces Sanofi's commitment to developing treatments for rare diseases Efdoralprin alfa, an investigational restorative recombinant therapy,

Reign Opens Literary Gallery to the Public, Showcasing American Civic History

Reign is pleased to announce the upcoming opening of its non-partisan literary gallery, a dedicated public exhibition space preserving and presenting rare printed materials, original artifacts, and culturalephemera from defining moments in American civic life. The Gallery's inaugural exhibitions focus on Franklin D. Roosevelt's New Deal, with particular emphasis on the Civilian Conservation Corps, National

Ampace and DG Matrix Announce Strategic Partnership to Deliver First UL-Certified Grid-Active BESS Integrated with Multi-Port Solid-State Transformer Architecture for AI Data Centers

Ampace, a global leader in advanced lithium-ion energy storage, today announced a strategic collaboration with DG Matrix to deliver the industry's first UL-certified, grid-active Battery Energy Storage System (BESS) integrated with a multi-port solid-state transformer (SST) platform. This milestone marks a major advancement in enabling safe, efficient, and AI-ready power infrastructure for next-generation data centers,

Scroll to Top